A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy

Kameda Medical Center, Kamogawa

The Jikei University Kashiwa Hospital, Kashiwa

Ogaki Municipal Hospital, Ōgaki

Gunma University Hospital, Maebashi

Shibukawa Medical Center, Shibukawa

Kobe city Medical Center General Hospital, Kobe

Kanazawa University Hospital, Kanazawa

Iwate Medical University, Morioka

Yokohama Municipal Citizen's Hospital, Yokohama

Suwa Red Cross Hospital, Suwa

Dokkyo Medical University, Koshigaya

Juntendo University Hospital, Bunkyo-ku

Nippon Medical School Hospital, Bunkyo-ku

Nihon University Itabashi Hospital, Itabashi-ku

The Cancer Institute Hospital of JFCR, Koto-ku

The Jikei University Hospital, Minato-ku

Kyorin University Hospital, Mitaka

Japanese Red Cross Medical Center, Shibuya-ku

Tokyo Disaster Medical Center, Tachikawa

Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima

Kyoto Kuramaguchi Medical Center, Kyoto

Niigata Cancer Center Hospital, Niigata

Osaka Red Cross Hospital, Osaka